Clinical Trial Details
EORTC-62012
Back to Clinical Trials Database
Randomised trial of single agent doxorubicin versus doxorubicin plus ifosfamide in the first line treatment of advanced or metastatic soft tissue sarcoma
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 08-Apr-2003 Date Step1 close: 25-May-2010 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 450 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00061984 |
| NCT number | NCT00061984 |
| EudraCT | 2004-002113-36 |
